Unlocking The Potential of CES1P2: A Pseudogene with Potential for Drug Targets and Biomarkers

Target Name: CES1P2

NCBI ID: G390732

CES1P2

Other Name(s): Carboxylesterase 1 pseudogene 2 | carboxylesterase 1 pseudogene 2

Unlocking The Potential of CES1P2: A Pseudogene with Potential for Drug Targets and Biomarkers

CES1P2 (Carboxylesterase 1 pseudogene 2) is a gene that encodes a protein known as CES1P2, which is a enzyme involved in the breakdown of fatty acids. The encoded protein is a pseudogene, which means that it was identified in the genomic sequence but does not have a functional gene. Despite this, CES1P2 has been shown to be involved in a number of cellular processes, including the regulation of lipid metabolism and cell signaling.

One of the reasons why CES1P2 has generated a lot of interest is because it has been implicated in a number of diseases, including obesity, type 2 diabetes, and cardiovascular disease. In addition, the study of its functional role in these diseases has the potential to identify new drug targets and biomarkers.

One of the key functions of CES1P2 is its role in the breakdown of fatty acids, which are an essential component of many cellular processes. Fatty acids are a source of energy for the cell and are also involved in the formation of many important molecules, including cell signaling pathways and membrane structures. However, when the body produces too many fatty acids, it can lead to a number of health problems, including obesity, type 2 diabetes, and cardiovascular disease.

CES1P2 has been shown to be involved in the regulation of lipid metabolism, which is the process by which the body produces and uses fat. In addition, the encoded protein has been shown to play a role in the breakdown of fatty acids, which is critical for the body's ability to properly use and store fat.

In addition to its role in lipid metabolism, CES1P2 has also been shown to be involved in a number of other cellular processes. For example, the encoded protein has been shown to be involved in the regulation of cellular signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.

Another function of CES1P2 is its role in the regulation of cellular apoptosis, which is the process by which cells die and are removed from the body. This is a natural and important process that helps the body to remove damaged or dysfunctional cells, but can also be a source of diseases, including cancer.

In addition to its role in apoptosis, CES1P2 has also been shown to be involved in the regulation of cellular signaling pathways that are involved in the development and progression of diseases, including cancer. For example, the encoded protein has been shown to be involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of cell growth, survival, and angiogenesis.

Despite the potential for CES1P2 to be a drug target or biomarker, much more research is needed to fully understand its functions and the potential implications of its study. For example, it is not yet clear what the exact function of CES1P2 is in the regulation of lipid metabolism, or how it is involved in the regulation of cellular signaling pathways. In addition, further studies are needed to determine the potential clinical applications of CES1P2 as a drug target or biomarker.

In conclusion, CES1P2 is a gene that has generated a lot of interest due to its potential involvement in a number of diseases, including obesity, type 2 diabetes, and cardiovascular disease. The encoded protein has been shown to play a role in the regulation of lipid metabolism and cellular signaling pathways, and has the potential to be a drug target or biomarker. Further research is needed to fully understand its functions and potential implications, and to determine its potential clinical applications.

Protein Name: Carboxylesterase 1 Pseudogene 2

The "CES1P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CES1P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets